Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach

Background/aim: Little is known about the prevalence and causes of pulmonary hypertension (PH) in Behçet’s disease (BD). This study was conducted to determine the prevalence and causes of PH in BD. Materials and methods: In this descriptive study, we screened 154 patients with BD for PH using transthoracic echocardiography between February 2017 and October 2017. An estimated systolic pulmonary arterial pressure (sPAP ≥ 40 mmHg) was used as the cut- off value to define PH. Patients with BD were categorized into 5 groups according to organ involvement including mucocutaneous/ articular, ocular, vascular, gastrointestinal, and neurologic involvement. Additional laboratory and imaging results were obtained from hospital file records to determine the causes of PH. Results: PH was detected in 17 (11%) patients. Nine (52.9%) of these patients had group II PH (due to left heart disease), 4 (23.5%) had IV PH (due to pulmonary arterial involvement), and 1 had III PH (due to chronic obstructive lung disease). The frequency of PH was higher in BD patients with vascular involvement than those without (52.9% vs 28.5%; p = 0.04). Among 10 patients with pulmonary artery involvement (PAI) 4 (40%) had PH. Although the vascular BD group had the highest rate of PH, we observed no statistically significant difference in the frequency of PH between the predefined BD subgroups. Conclusions: PH is not rare in patients with BD. The majority of BD patients with PH are in group II or IV PH. Patients with vascular involvement carry a higher risk for the development of PH. Monitoring BD patients with PAI should be considered for the development of group IV PH.

Anahtar Kelime: Behçet’s disease pulmonary hypertension pulmonary involvement pulmonary arterial involvement echocardiography

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Hatemi G, Yazici Y, Yazici H. Behçet’s syndrome. Rheumatic Disease Clinics North America 2013; 39: 245–261. doi: 10.1016/j.rdc.2013.02.010
2. Seyahi E, Melikoglu M, Akman C, Hamuryudan V, Ozer H et al. Pulmonary artery involvement and associated lung disease in Behçet disease: A series of 47 patients. Medicine (Baltimore) 2012; 91: 35–48. doi: 10.1097/MD.0b013e318242ff37
3. Seyahi E, Baskurt M, Melikoglu M, Akman C, Olgun DC et al. The estimated pulmonary artery pressure can be elevated in Behçet’s syndrome. Respiratory Medicine 2011; 105: 1739– 1747. doi: 10.1016/j.rmed.2011.07.022
4. Skef W, Hamilton MJ, Arayssi T. Gastrointestinal Behçet’s disease: a review. World Journal of Gastroenterology 2015; 21(13): 3801-3812. doi:10.3748/wjg.v21.i13.3801
5. Hoeper MM, Humbert M. The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally! European respiratory journal 2019; 53(3): 1900038. doi: 10.1183/13993003.00038-2019
6. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). European Respiratory Journal 2015; 46: 903-975. doi: 10.1183/13993003.01032-2015
7. George PM, Oliver E, Dorfmuller P, Dubois OD, Reed DM et al. Evidence for the involvement of type I interferon in pulmonary arterial hypertension. Circulation Research 2014; 114: 677–688. doi: 10.1161/CIRCRESAHA.114.302221
8. Santana AN, Antunes T, Barros JM, Kairalla RA, Carvalho CR et al. Pulmonary involvement in Behcet’s disease: a positive single-center experience with the use of immunosuppressive therapy. Jornal Brasileiro de Pneumolgia 2008; 34: 362–366. doi: 10.1590/s1806-37132008000600005
9. Esatoglu SN, Seyahi E, Ugurlu S, Gulsen F, Akman C, et al. Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behçet’s syndrome patients with pulmonary artery involvement during follow-up. Clinical and experimental rheumatology 2016; 34 (102): 92-96.
10. International Study Group for Behcet’s Disease. Criteria for diagnosis of Behcet’s disease. Lancet 1990; 335: 1078-1080.
11. Yazıcı H, Seyahi E. Behçet syndrome: the vascular cluster. Turkish Journal of Medical Sciences 2016; 46(5): 1277-1280. doi: 10.3906/sag-1605-28
12. Soejima Y, Kirino Y, Takeno M, Kurosawa M, Takeuchi M et al. Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan. Arthritis Research & Therapy 2021; 23(1): 49. doi: 10.1186/s13075-020- 02406-6
13. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European association of Cardiovascular Imaging. Journal of the American Society of Echocardiography 2015; 28: 1-39. doi: 10.1016/j. echo.2014.10.003
14. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography 2016; 29: 277–314. doi: 10.1016/j.echo.2016.01.011
15. Heper G, Polat M, Yetkin E, Senen K. Cardiac findings in Behçet’s patients. The International Journal of Dermatology 2010; 49(5): 574-578. doi: 10.1111/j.1365-4632.2010.04424.x
16. Yavuz B, Sahiner L, Akdogan A, Abali G, Aytemir K et al. Left and right ventricular function is impaired in Behçet’s disease. Echocardiography 2006; 23: 723-728. doi: 10.1111/j.1540- 8175.2006.00301.x
17. Lee I, Park S, Hwang I, Kim MJ, Nah SS et al. Cardiac Behçet disease presenting as aortic valvulitis/aortitis or right heart inflammatory mass: a clinicopathologic study of 12 cases. The American Journal of Surgical Pathology 2008; 32: 390-398. doi: 10.1097/PAS.0b013e31814b23da
18. Hoeper MM, Lam CSP, Vachiery JL, Bauersachs J, Gerges C et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research. European Heart Journal 2017; 38: 2869–2873. doi: 10.1093/eurheartj/ehw597
19. Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y et al. Pathologic features of Behçet’s syndrome: a review of Japanese autopsy registry data. Human Pathology 1985; 16: 790-795. doi: 10.1016/s0046-8177(85)80250-1
20. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM et al. Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Annals of the Rheumatic Diseases 2009; 68: 1528-1534. doi: 10.1136/ard.2008.087957
21. Miniati M, Monti S, Bottai M, Scoscia E, Bauleo C et al. Survival and restoration of pulmonary perfusion in a long- term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore) 2006; 85: 253–262. doi: 10.1097/01. md.0000236952.87590.c8
22. Morris TA. Why acute pulmonary embolism becomes chronic thromboembolic pulmonary hypertension: clinical and genetic insights. Current Opinion in Pulmonary Medicine 2013; 19: 422–429. doi: 10.1097/MCP.0b013e328364379f
23. Yıldızeli ŞO, Yanartaş M, Taş S, Direskeneli H, Mutlu B et al. Outcomes of Patients with Behçet’s Syndrome after Pulmonary Endarterectomy. The Thoracic and Cardiovascular Surgeon 2018; 66: 187-192. doi: 10.1055/s-0037-1604411
24. Kingston M, Ratcliffe JR, Alltree M, Merendino KA. Aneurysm after arterial puncture in Behçet’s disease. British Medical Journal 1979; 30: 1766-1767. doi: 10.1136/bmj.1.6180.1766-a
25. Tuzun H, Seyahi E, Arslan C, Hamuryudan V, Besirli K et al. Management and prognosis of nonpulmonary large arterial in patients with Behçet disease. Journal of Vascular Surgery 2012; 55: 157-163. doi: 10.1016/j.jvs.2011.07.049
26. Seyahi E. Behçet’s disease: How to diagnose and treat vascular involvement. Best Practice & Research Clinical Rheumatology 2016; 30: 279-295. doi: 10.1016/j.berh.2016.08.002
27. George PM, Cunningham ME, Galloway-Phillipps N, Badiger R, Alazawi W et al. Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicity. Pulmonary Circulation 2012; 2: 501–504. doi: 10.4103/2045- 8932.105039
28. Savale L, Sattler C, Günther S, Montani D, Chaumais MC et al. Pulmonary arterial hypertension in patients treated with interferon. European Respiratory Journal 2014; 44: 1627-1634. doi: 10.1183/09031936.00057914
29. Lian F, Chen D, Wang Y, Ye Y, Wang X et al. Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus. Rheumatology International 2012; 32: 1727-1731. doi: 10.1007/s00296-011-1880-4
30. Lee GY, Jang SY, Ko SM, Kim EK, Lee Sh et al. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: Analysis of 204 Korean patients at a single center. International Journal of Cardiology 2012; 159: 14-20. doi: 10.1016/j.ijcard.2011.01.094

APA	Armagan B, Okşul M, ŞENER Y, SARI A, erden a, Yardimci G, Hayran M, Kılıç L, Karadag O, KAYA E, Tokgozoglu L, Ertenli I, Akdogan A (2023). Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach. , 563 - 571. 10.55730/1300-0144.5617
Chicago	Armagan Berkan,Okşul Metin,ŞENER Yusuf Ziya,SARI ALPER,erden abdulsamet,Yardimci Gozde Kubra,Hayran Mutlu,Kılıç Levent,Karadag Omer,KAYA ERGUN BARIS,Tokgozoglu Lale,Ertenli Ihsan,Akdogan Ali Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach. (2023): 563 - 571. 10.55730/1300-0144.5617
MLA	Armagan Berkan,Okşul Metin,ŞENER Yusuf Ziya,SARI ALPER,erden abdulsamet,Yardimci Gozde Kubra,Hayran Mutlu,Kılıç Levent,Karadag Omer,KAYA ERGUN BARIS,Tokgozoglu Lale,Ertenli Ihsan,Akdogan Ali Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach. , 2023, ss.563 - 571. 10.55730/1300-0144.5617
AMA	Armagan B,Okşul M,ŞENER Y,SARI A,erden a,Yardimci G,Hayran M,Kılıç L,Karadag O,KAYA E,Tokgozoglu L,Ertenli I,Akdogan A Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach. . 2023; 563 - 571. 10.55730/1300-0144.5617
Vancouver	Armagan B,Okşul M,ŞENER Y,SARI A,erden a,Yardimci G,Hayran M,Kılıç L,Karadag O,KAYA E,Tokgozoglu L,Ertenli I,Akdogan A Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach. . 2023; 563 - 571. 10.55730/1300-0144.5617
IEEE	Armagan B,Okşul M,ŞENER Y,SARI A,erden a,Yardimci G,Hayran M,Kılıç L,Karadag O,KAYA E,Tokgozoglu L,Ertenli I,Akdogan A "Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach." , ss.563 - 571, 2023. 10.55730/1300-0144.5617
ISNAD	Armagan, Berkan vd. "Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach". (2023), 563-571. https://doi.org/10.55730/1300-0144.5617

APA	Armagan B, Okşul M, ŞENER Y, SARI A, erden a, Yardimci G, Hayran M, Kılıç L, Karadag O, KAYA E, Tokgozoglu L, Ertenli I, Akdogan A (2023). Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach. Turkish Journal of Medical Sciences, 53(2), 563 - 571. 10.55730/1300-0144.5617
Chicago	Armagan Berkan,Okşul Metin,ŞENER Yusuf Ziya,SARI ALPER,erden abdulsamet,Yardimci Gozde Kubra,Hayran Mutlu,Kılıç Levent,Karadag Omer,KAYA ERGUN BARIS,Tokgozoglu Lale,Ertenli Ihsan,Akdogan Ali Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach. Turkish Journal of Medical Sciences 53, no.2 (2023): 563 - 571. 10.55730/1300-0144.5617
MLA	Armagan Berkan,Okşul Metin,ŞENER Yusuf Ziya,SARI ALPER,erden abdulsamet,Yardimci Gozde Kubra,Hayran Mutlu,Kılıç Levent,Karadag Omer,KAYA ERGUN BARIS,Tokgozoglu Lale,Ertenli Ihsan,Akdogan Ali Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach. Turkish Journal of Medical Sciences, vol.53, no.2, 2023, ss.563 - 571. 10.55730/1300-0144.5617
AMA	Armagan B,Okşul M,ŞENER Y,SARI A,erden a,Yardimci G,Hayran M,Kılıç L,Karadag O,KAYA E,Tokgozoglu L,Ertenli I,Akdogan A Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach. Turkish Journal of Medical Sciences. 2023; 53(2): 563 - 571. 10.55730/1300-0144.5617
Vancouver	Armagan B,Okşul M,ŞENER Y,SARI A,erden a,Yardimci G,Hayran M,Kılıç L,Karadag O,KAYA E,Tokgozoglu L,Ertenli I,Akdogan A Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach. Turkish Journal of Medical Sciences. 2023; 53(2): 563 - 571. 10.55730/1300-0144.5617
IEEE	Armagan B,Okşul M,ŞENER Y,SARI A,erden a,Yardimci G,Hayran M,Kılıç L,Karadag O,KAYA E,Tokgozoglu L,Ertenli I,Akdogan A "Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach." Turkish Journal of Medical Sciences, 53, ss.563 - 571, 2023. 10.55730/1300-0144.5617
ISNAD	Armagan, Berkan vd. "Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach". Turkish Journal of Medical Sciences 53/2 (2023), 563-571. https://doi.org/10.55730/1300-0144.5617